These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

487 related articles for article (PubMed ID: 36741965)

  • 1. High expression of TMEM200A is associated with a poor prognosis and immune infiltration in gastric cancer.
    Deng H; Li T; Wei F; Han W; Xu X; Zhang Y
    Pathol Oncol Res; 2023; 29():1610893. PubMed ID: 36741965
    [No Abstract]   [Full Text] [Related]  

  • 2. TMEM200A is a potential prognostic biomarker and correlated with immune infiltrates in gastric cancer.
    Fang F; Zhang T; Lei H; Shen X
    PeerJ; 2023; 11():e15613. PubMed ID: 37404478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and validation of the prognostic value of cyclic GMP-AMP synthase-stimulator of interferon (cGAS-STING) related genes in gastric cancer.
    Yang KS; Xu CQ; Lv J
    Bioengineered; 2021 Dec; 12(1):1238-1250. PubMed ID: 33843442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokine-Like Protein 1 (CYTL1) as a Key Target of M-Stage Immune Infiltration in Stomach Adenocarcinoma.
    Zhou F; Lin Q; Zheng Z
    Biomed Res Int; 2023; 2023():2926218. PubMed ID: 36825034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Construction of mRNA prognosis signature associated with differentially expressed genes in early stage of stomach adenocarcinomas based on TCGA and GEO datasets.
    Jiang F; Lin H; Yan H; Sun X; Yang J; Dong M
    Eur J Med Res; 2022 Oct; 27(1):205. PubMed ID: 36253873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation analysis of lipid metabolism genes with the immune microenvironment in gastric cancer and the construction of a novel gene signature.
    Li Y; Chen X; Zhang R; Chen M; Shen J; Wu J; Yu J; Sun Q
    Clin Transl Oncol; 2023 May; 25(5):1315-1331. PubMed ID: 36520384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune Landscape of Gastric Carcinoma Tumor Microenvironment Identifies a Peritoneal Relapse Relevant Immune Signature.
    Zhang C; Li D; Yu R; Li C; Song Y; Chen X; Fan Y; Liu Y; Qu X
    Front Immunol; 2021; 12():651033. PubMed ID: 34054812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and validation of biomarkers for epithelial-mesenchymal transition-related cells to estimate the prognosis and immune microenvironment in primary gastric cancer by the integrated analysis of single-cell and bulk RNA sequencing data.
    Shen K; Ke S; Chen B; Zhang T; Wang H; Lv J; Gao W
    Math Biosci Eng; 2023 Jun; 20(8):13798-13823. PubMed ID: 37679111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BASP1 expression is associated with poor prognosis and is correlated with immune infiltration in gastric cancer.
    Wang T; Liu X; Wang T; Zhan L; Zhang M
    FEBS Open Bio; 2023 Aug; 13(8):1507-1521. PubMed ID: 37243901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction of a gene model related to the prognosis of patients with gastric cancer receiving immunotherapy and exploration of COX7A1 gene function.
    Wang SY; Wang YX; Shen A; Yang XQ; Liang CC; Huang RJ; Jian R; An N; Xiao YL; Wang LS; Zhao Y; Lin C; Wang CP; Yuan ZP; Yuan SQ
    Eur J Med Res; 2024 Mar; 29(1):180. PubMed ID: 38494472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a basement membrane-related genes signature to predict prognosis, immune landscape and guide therapy in gastric cancer.
    Liu ZY; Xin L
    Medicine (Baltimore); 2023 Sep; 102(39):e35027. PubMed ID: 37773804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. KIF2C is a prognostic biomarker associated with immune cell infiltration in breast cancer.
    Liu S; Ye Z; Xue VW; Sun Q; Li H; Lu D
    BMC Cancer; 2023 Apr; 23(1):307. PubMed ID: 37016301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulated CANT1 is correlated with poor prognosis in hepatocellular carcinoma.
    Liu T; Li ZZ; Sun L; Yang K; Chen JM; Han XY; Qi LM; Zhou XG; Wang P
    BMC Cancer; 2023 Oct; 23(1):1007. PubMed ID: 37858061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of immune infiltration-related genes as prognostic indicators for hepatocellular carcinoma.
    Dai K; Liu C; Guan G; Cai J; Wu L
    BMC Cancer; 2022 May; 22(1):496. PubMed ID: 35513781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated single-cell RNA sequencing analysis reveals a mesenchymal stem cell-associated signature for estimating prognosis and drug sensitivity in gastric cancer.
    Shen K; Chen B; Gao W
    J Cancer Res Clin Oncol; 2023 Oct; 149(13):11829-11847. PubMed ID: 37410142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CCDC25 may be a potential diagnostic and prognostic marker of hepatocellular carcinoma: Results from microarray analysis.
    Deng H; Zhang J; Zheng Y; Li J; Xiao Q; Wei F; Han W; Xu X; Zhang Y
    Front Surg; 2022; 9():878648. PubMed ID: 36211267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of
    Wang Y; Fang Y; Zhao F; Gu J; Lv X; Xu R; Zhang B; Fang Z; Li Y
    Front Genet; 2022; 13():810292. PubMed ID: 35368661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased IGFBP7 Expression Correlates with Poor Prognosis and Immune Infiltration in Gastric Cancer.
    Zhao Q; Zhao R; Song C; Wang H; Rong J; Wang F; Yan L; Song Y; Xie Y
    J Cancer; 2021; 12(5):1343-1355. PubMed ID: 33531979
    [No Abstract]   [Full Text] [Related]  

  • 19. Multiomics Analysis of TMEM200A as a Pan-Cancer Biomarker.
    Zhang Y; Kuang S; Qin H; Zhao N; Yang Y; Xie J
    J Vis Exp; 2023 Sep; (199):. PubMed ID: 37782103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High expression of the circadian clock gene NPAS2 is associated with progression and poor prognosis of gastric cancer: A single-center study.
    Cao XM; Kang WD; Xia TH; Yuan SB; Guo CA; Wang WJ; Liu HB
    World J Gastroenterol; 2023 Jun; 29(23):3645-3657. PubMed ID: 37398880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.